Compositions and Methods for Cellular Ageing, Stress Resilience, Autophagy, Inflammation and Longevity
Abstract
Compositions and methods are presented that help reduce cellular ageing, improve cellular stress resilience, and/or promote increased longevity. Especially preferred compositions include a combination of a purine alkaloid, an isothiocyanate or thioglucoside, and a metal-containing antioxidant, where the purine alkaloid, the isothiocyanate or thioglucoside, and the metal-containing antioxidant may be chemically isolated compounds or extracts or other preparations from naturally occurring entities such as plants, bacteria, yeast, etc. Advantageously, contemplated compositions will be effective to reduce and repair oxidative stress, improve mitochondrial function, augment DNA repair and telomere maintenance, increase fatty acid metabolism, and modulate histone deacetylation.
Claims
exact text as granted — not AI-modified1 . A composition for reducing cellular ageing, improving cellular stress resilience, and/or increasing longevity, comprising:
a cytoprotective formulation comprising a combination of (a) theacrine, (b) an isothiocyanate, and (c) a copper-(I)-nicotinate complex; wherein the cytoprotective formulation is formulated for oral administration with a nutritionally or pharmaceutically acceptable carrier, or for topical administration; and wherein the theacrine, the isothiocyanate, and the copper-(I)-nicotinate complex are present in the composition in amounts that upregulate gene expression of SIRT1 to thereby reduce cellular ageing, improve cellular stress resilience, and/or increase longevity.
2 . The composition of claim 1 , wherein the theacrine is present in and provided as a Camellia sp., Theobroma sp., or Coffea sp. extract.
3 . (canceled)
4 . (canceled)
5 . The composition of claim 1 , wherein the isothiocyanate is allyl isothiocyanate or 2-phenylethyl isothiocyanate.
6 . (canceled)
7 . The composition of claim 1 , wherein the composition further comprises one or more additional nutritional ingredients.
8 . The composition of claim 7 , wherein the one or more additional nutritional ingredients include a ketogenic compound.
9 . The composition of claim 8 , wherein the ketogenic compound is acetoacetate, butyrate, polyhydroxybutyrate (PHB), beta-hydroxybutyrate (BHB), or combinations thereof.
10 . The composition of claim 7 , wherein the one or more additional nutritional ingredients include a SIRT enhancing agent.
11 . The composition of claim 10 wherein the SIRT enhancing agent is fisetin, resveratrol, quercetin, or a catechin.
12 . The composition of claim 7 , wherein the one or more additional nutritional ingredients includes a NAD enhancing agent.
13 . The composition of claim 12 , wherein the NAD enhancing agent is niacinamide, nicotinamide mononucleotide (NMN), or niacin.
14 . The composition of claim 7 , wherein the one or more additional nutritional ingredients include tributyrin.
15 . The composition of claim 7 , wherein the one or more additional nutritional ingredient include selenium.
16 . The composition of claim 7 , wherein the one or more additional nutritional ingredients include niacinamide, nicotinamide riboside alternative (NAD3), selenium, olive leaf, a polyphenol, BHB, and/or tributyrin.
17 . The composition of claim 16 , wherein the polyphenol is grape seed extract.
18 .- 25 . (canceled)
26 . The composition of claim 1 formulated for oral administration to a mammal.
27 . The composition of claim 1 , wherein the isothiocyanate is provided by a wasabi extract.
28 . The composition of claim 26 , wherein the isothiocyanate is provided by a wasabi extract.Join the waitlist — get patent alerts
Track US2023149488A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.